These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


271 related items for PubMed ID: 27998305

  • 1. Cytotoxicity of Plumbagin, Rapanone and 12 other naturally occurring Quinones from Kenyan Flora towards human carcinoma cells.
    Kuete V, Omosa LK, Tala VR, Midiwo JO, Mbaveng AT, Swaleh S, Karaosmanoğlu O, Sivas H.
    BMC Pharmacol Toxicol; 2016 Dec 21; 17(1):60. PubMed ID: 27998305
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxicity of the methanol extracts of Elephantopus mollis, Kalanchoe crenata and 4 other Cameroonian medicinal plants towards human carcinoma cells.
    Kuete V, Fokou FW, Karaosmanoğlu O, Beng VP, Sivas H.
    BMC Complement Altern Med; 2017 May 25; 17(1):280. PubMed ID: 28545532
    [Abstract] [Full Text] [Related]

  • 3. Cytotoxicity of naturally occurring phenolics and terpenoids from Kenyan flora towards human carcinoma cells.
    Kuete V, Omosa LK, Midiwo JO, Karaosmanoğlu O, Sivas H.
    J Ayurveda Integr Med; 2019 May 25; 10(3):178-184. PubMed ID: 30389223
    [Abstract] [Full Text] [Related]

  • 4. Cytotoxicity of seputhecarpan D, thonningiol and 12 other phytochemicals from African flora towards human carcinoma cells.
    Kuete V, Ngnintedo D, Fotso GW, Karaosmanoğlu O, Ngadjui BT, Keumedjio F, Yeboah SO, Andrae-Marobela K, Sivas H.
    BMC Complement Altern Med; 2018 Jan 30; 18(1):36. PubMed ID: 29378558
    [Abstract] [Full Text] [Related]

  • 5. Cytotoxicity of anthraquinones from the roots of Pentas schimperi towards multi-factorial drug-resistant cancer cells.
    Kuete V, Donfack AR, Mbaveng AT, Zeino M, Tane P, Efferth T.
    Invest New Drugs; 2015 Aug 30; 33(4):861-9. PubMed ID: 26115800
    [Abstract] [Full Text] [Related]

  • 6. Cytotoxicity and modes of action of three naturally occurring xanthones (8-hydroxycudraxanthone G, morusignin I and cudraxanthone I) against sensitive and multidrug-resistant cancer cell lines.
    Kuete V, Sandjo LP, Ouete JL, Fouotsa H, Wiench B, Efferth T.
    Phytomedicine; 2014 Feb 15; 21(3):315-22. PubMed ID: 24075210
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Activity of three cytotoxic isoflavonoids from Erythrina excelsa and Erythrina senegalensis (neobavaisoflavone, sigmoidin H and isoneorautenol) toward multi-factorial drug resistant cancer cells.
    Kuete V, Sandjo LP, Kwamou GM, Wiench B, Nkengfack AE, Efferth T.
    Phytomedicine; 2014 Apr 15; 21(5):682-8. PubMed ID: 24252341
    [Abstract] [Full Text] [Related]

  • 17. Cytotoxicity of two naturally occurring flavonoids (dorsmanin F and poinsettifolin B) towards multi-factorial drug-resistant cancer cells.
    Kuete V, Mbaveng AT, Zeino M, Ngameni B, Kapche GD, Kouam SF, Ngadjui BT, Efferth T.
    Phytomedicine; 2015 Jul 15; 22(7-8):737-43. PubMed ID: 26141760
    [Abstract] [Full Text] [Related]

  • 18. Cytotoxicity and modes of action of 4'-hydroxy-2',6'-dimethoxychalcone and other flavonoids toward drug-sensitive and multidrug-resistant cancer cell lines.
    Kuete V, Nkuete AH, Mbaveng AT, Wiench B, Wabo HK, Tane P, Efferth T.
    Phytomedicine; 2014 Oct 15; 21(12):1651-7. PubMed ID: 25442273
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cytotoxic flavonoids and isoflavonoids from Erythrina sigmoidea towards multi-factorial drug resistant cancer cells.
    Kuete V, Sandjo LP, Djeussi DE, Zeino M, Kwamou GM, Ngadjui B, Efferth T.
    Invest New Drugs; 2014 Dec 15; 32(6):1053-62. PubMed ID: 25034000
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.